Psychopharmacological and Other Treatments in Preschool Children with Attention-Deficit/Hyperactivity Disorder: Current Evidence and Practice

Por Ghuman, Jaswinder K., Arnold, L. Eugene, Anthony, Bruno J.
Publicado em 2008

Pharmacological Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: Clinical Strategies

Por Shier, Anna C., Reichenbacher, Thomas, Ghuman, Harinder S., Ghuman, Jaswinder K.
Publicado em 2012

The Screen for Social Interaction (SSI): A Screening Measure for Autism Spectrum Disorders in Preschoolers

Por Ghuman, Jaswinder K., Leone, Sarah L., Lecavalier, Luc, Landa, Rebecca J.
Publicado em 2011

Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review

Por Hutchison, Shari L., Ghuman, Jaswinder K., Ghuman, Harinder S., Karpov, Irina, Schuster, James M.
Publicado no Ther Adv Psychopharmacol (2016)

Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder

Por Upadhyaya, Himanshu, Kratochvil, Christopher, Ghuman, Jaswinder, Camporeale, Angelo, Lipsius, Sarah, D'Souza, Deborah, Tanaka, Yoko
Publicado no J Child Adolesc Psychopharmacol (2015)

Prospective, Naturalistic, Pilot Study of Open-Label Atomoxetine Treatment in Preschool Children with Attention-Deficit/Hyperactivity Disorder

Por Ghuman, Jaswinder K., Aman, Michael G., Ghuman, Harinder S., Reichenbacher, Thomas, Gelenberg, Alan, Wright, Ron, Rice, Sydney, Fort, Carolyn
Publicado em 2009

Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental Disorders

Por Ghuman, Jaswinder K., Aman, Michael G., Lecavalier, Luc, Riddle, Mark A., Gelenberg, Alan, Wright, Ron, Rice, Sydney, Ghuman, Harinder S., Fort, Carolyn
Publicado em 2009

Positive Effects of Methylphenidate on Social Communication and Self-Regulation in Children with Pervasive Developmental Disorders and Hyperactivity

Por Jahromi, Laudan B., Kasari, Connie L., McCracken, James T., Lee, Lisa S-Y., Aman, Michael G., McDougle, Christopher J., Scahill, Lawrence, Tierney, Elaine, Arnold, L. Eugene, Vitiello, Benedetto, Ritz, Louise, Witwer, Andrea, Kustan, Erin, Ghuman, Jaswinder, Posey, David J.
Publicado no J Autism Dev Disord (2008)

Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior

Por Aman, Michael G., Hollway, Jill A., McDougle, Christopher J., Scahill, Lawrence, Tierney, Elaine, McCracken, James T., Arnold, L. Eugene, Vitiello, Benedetto, Ritz, Louise, Gavaletz, Allison, Cronin, Pegeen, Swiezy, Naomi, Wheeler, Courtney, Koenig, Kathleen, Ghuman, Jaswinder K., Posey, David J.
Publicado em 2008

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial

Por Aman, Michael, Rettiganti, Mallikarjuna, Nagaraja, Haikady N., Hollway, Jill A., McCracken, James, McDougle, Christopher J., Tierney, Elaine, Scahill, Lawrence, Arnold, L. Eugene, Hellings, Jessica, Posey, David J., Swiezy, Naomi B., Ghuman, Jaswinder, Grados, Marco, Shah, Bhavik, Vitiello, Benedetto
Publicado no J Child Adolesc Psychopharmacol (2015)